The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa
Antibiotic resistance carries a fitness cost that must be overcome in order for resistance to persist over the long term. Compensatory mutations that recover the functional defects associated with resistance mutations have been argued to play a key role in overcoming the cost of resistance, but comp...
| Główni autorzy: | , , , , |
|---|---|
| Format: | Journal article |
| Język: | English |
| Wydane: |
Royal Society
2016
|
| _version_ | 1826288821195505664 |
|---|---|
| author | Qi, Q Toll-Riera, M Heilbron, K Preston, G MacLean, R |
| author_facet | Qi, Q Toll-Riera, M Heilbron, K Preston, G MacLean, R |
| author_sort | Qi, Q |
| collection | OXFORD |
| description | Antibiotic resistance carries a fitness cost that must be overcome in order for resistance to persist over the long term. Compensatory mutations that recover the functional defects associated with resistance mutations have been argued to play a key role in overcoming the cost of resistance, but compensatory mutations are expected to be rare relative to generally beneficial mutations that increase fitness, irrespective of antibiotic resistance. Given this asymmetry, population genetics theory predicts that populations should adapt by compensatory mutations when the cost of resistance is large, whereas generally beneficial mutations should drive adaptation when the cost of resistance is small. We tested this prediction by determining the genomic mechanisms underpinning adaptation to antibiotic-free conditions in populations of the pathogenic bacterium Pseudomonas aeruginosa that carry costly antibiotic resistance mutations. Whole-genome sequencing revealed that populations founded by high-cost rifampicin-resistant mutants adapted via compensatory mutations in three genes of the RNA polymerase core enzyme, whereas populations founded by low-cost mutants adapted by generally beneficial mutations, predominantly in the quorum-sensing transcriptional regulator gene lasR. Even though the importance of compensatory evolution in maintaining resistance has been widely recognized, our study shows that the roles of general adaptation in maintaining resistance should not be underestimated and highlights the need to understand how selection at other sites in the genome influences the dynamics of resistance alleles in clinical settings. |
| first_indexed | 2024-03-07T02:19:30Z |
| format | Journal article |
| id | oxford-uuid:a36b2e64-1cae-45ef-99fb-4851c0fa0a2d |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:19:30Z |
| publishDate | 2016 |
| publisher | Royal Society |
| record_format | dspace |
| spelling | oxford-uuid:a36b2e64-1cae-45ef-99fb-4851c0fa0a2d2022-03-27T02:26:49ZThe genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a36b2e64-1cae-45ef-99fb-4851c0fa0a2dEnglishSymplectic Elements at OxfordRoyal Society2016Qi, QToll-Riera, MHeilbron, KPreston, GMacLean, RAntibiotic resistance carries a fitness cost that must be overcome in order for resistance to persist over the long term. Compensatory mutations that recover the functional defects associated with resistance mutations have been argued to play a key role in overcoming the cost of resistance, but compensatory mutations are expected to be rare relative to generally beneficial mutations that increase fitness, irrespective of antibiotic resistance. Given this asymmetry, population genetics theory predicts that populations should adapt by compensatory mutations when the cost of resistance is large, whereas generally beneficial mutations should drive adaptation when the cost of resistance is small. We tested this prediction by determining the genomic mechanisms underpinning adaptation to antibiotic-free conditions in populations of the pathogenic bacterium Pseudomonas aeruginosa that carry costly antibiotic resistance mutations. Whole-genome sequencing revealed that populations founded by high-cost rifampicin-resistant mutants adapted via compensatory mutations in three genes of the RNA polymerase core enzyme, whereas populations founded by low-cost mutants adapted by generally beneficial mutations, predominantly in the quorum-sensing transcriptional regulator gene lasR. Even though the importance of compensatory evolution in maintaining resistance has been widely recognized, our study shows that the roles of general adaptation in maintaining resistance should not be underestimated and highlights the need to understand how selection at other sites in the genome influences the dynamics of resistance alleles in clinical settings. |
| spellingShingle | Qi, Q Toll-Riera, M Heilbron, K Preston, G MacLean, R The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa |
| title | The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa |
| title_full | The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa |
| title_fullStr | The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa |
| title_full_unstemmed | The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa |
| title_short | The genomic basis of adaptation to the fitness cost of rifampicin resistance in Pseudomonas aeruginosa |
| title_sort | genomic basis of adaptation to the fitness cost of rifampicin resistance in pseudomonas aeruginosa |
| work_keys_str_mv | AT qiq thegenomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT tollrieram thegenomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT heilbronk thegenomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT prestong thegenomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT macleanr thegenomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT qiq genomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT tollrieram genomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT heilbronk genomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT prestong genomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa AT macleanr genomicbasisofadaptationtothefitnesscostofrifampicinresistanceinpseudomonasaeruginosa |